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Membrane transportersGenome analysis of the yeast Saccharomyces cerevisiae identiﬁed 68 genes encoding ﬂavin-dependent proteins
(1.1% of protein encoding genes) to which 47 distinct biochemical functions were assigned. The majority of ﬂa-
voproteins operate in mitochondria where they participate in redox processes revolving around the transfer of
electrons to the electron transport chain. In addition, we found that ﬂavoenzymes play a central role in various
aspects of iron metabolism, such as iron uptake, the biogenesis of iron–sulfur clusters and insertion of the
heme cofactor into apocytochromes. Another important group of ﬂavoenzymes is directly (Dus1-4p and
Mto1p) or indirectly (Tyw1p) involved in reactions leading to tRNA-modiﬁcations. Despite thewealth of genetic
information available for S. cerevisiae, we were surprised that many ﬂavoproteins are poorly characterized bio-
chemically. For example, the role of the yeast ﬂavodoxins Pst2p, Rfs1p and Ycp4p with regard to their electron
donor and acceptor is presently unknown. Similarly, the function of the heterodimeric Aim45p/Cir1p, which is
homologous to the electron-transferring ﬂavoproteins of higher eukaryotes, in electron transfer processes occur-
ring in themitochondrial matrix remains to be elucidated. This lack of information extends to the ﬁvemembrane
proteins involved in riboﬂavin or FAD transport as well as FMN and FAD homeostasis within the yeast cell. Nev-
ertheless, several yeast ﬂavoproteins, were identiﬁed as convenient model systems both in terms of their mech-
anism of action as well as structurally to improve our understanding of diseases caused by dysfunctional human
ﬂavoprotein orthologs.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction to the history of Flavoprotein discovery
The yeast Saccharomyces cerevisiae played a central role in the
discovery of ﬂavoproteins as Otto Warburg and his collaborators
were the ﬁrst to isolate a “yellow ferment” from yeast cells [1]. Fur-
ther studies by Theorell led to the concept of reversible association
of co-enzyme and apo-enzyme to form the active holo-enzyme [2].
The isolation of other (new) yellow ferments from yeast prompted
the renaming of the original ferment in to “old yellow ferment”
(old yellow enzyme = OYE) [3]. Although it was demonstrated
that OYE is reduced by NADPH [1,4] the physiological electron
accepting substrate(s) remains uncertain despite its reported role
in the maintenance of the cytoskeleton [5]. This may have contributedate; DHBP, 3,4-dihydroxy-2-
ino)-4-(3H)-pyrimidinone 5′-
sport chain; Gly3p, glycerol 3-
, mitochondrial intermembrane
ding frame; Q, ubiquionone
43 316 873 6952.
roux).
. Open access under CC BY-NC-ND licensto the persistent use of OYE instead of the ofﬁcial classiﬁcation as
NAD(P)H dehydrogenase (EC 1.6.99.1).
Despite the elusive nature of the physiological substrate(s), OYE
rapidly developed in to an important model ﬂavoenzyme culminat-
ing in the determination of the nucleotide sequence of oye2 and
oye3 as well as the elucidation of its three-dimensional structure by
X-ray crystallography [6–8]. The detailed biochemical characterisa-
tion of OYE also led to the identiﬁcation of a number of artiﬁcial
substrates, such as N-ethylmaleimide, cyclohex-2-enone and
nitrooleﬁns [8–10]. All of these substrates share a common structural
motif consisting of an electron-withdrawing group (e.g. a carbonyl
or nitro group) in α-position of a carbon–carbon double bond. The
remarkably broad range of accepted substrates rendered OYE an
ideal tool for biocatalytic applications exploited in numerous studies
[11–15]. These efforts were further stimulated by the discovery of
OYE homologs in many eubacteria as well as plant species in the
1990s [16–23]. Plant OYE homologs were of particular interest be-
cause of their well-deﬁned role in the biosynthesis of the plant hor-
mone jasmonate, which plays a crucial role in the plant's defense
response to pathogens [24,25]. In all reported cases, the natural sub-
strates exhibited the structural motif discovered in previous studies
with yeast OYE. Hence, the yeast enzyme also became the paradigm
for the class of “ene-reductases” nowwidely used for the synthesis of
a variety of useful chemicals. Curiously, the broad range of activated
“enes” accepted by OYEs as substrates is in stark contrast to itse.
Table 1
Yeast ﬂavoproteins and genes.
No. E.C. Enzyme Cofactor Structure clan (family)a Localization Abbrev. Syst. name
1 1.1.2.3 L-Lactate:cytochrome c oxidoreductase
(ﬂavocytochrome b2)
FMN/heme TIM_barrel (FMN_dh) Mito. intermembr. sp. cyb2 YML054C
2 1.1.2.4 D-Lactate dehydrogenase FAD/heme – I. mito. membr. dld1 YDL174C
Mito. matrix dld2 YDL178W
Cytoplasm dld3 YEL071W
3 1.1.3.37 D-Arabino-1,4-lactone oxidase 8α-(N3-His)
-FAD
FAD_PCMH O. mito. membr. alo1 YML086C
4 1.1.5.3 Glycerol-3-phosphate dehydrogenase FAD NADP_Rossmann (DAO) I. mito. membr. gut2 YIL155C
5 1.3.1.90 tRNA dihydrouridine synthase FMN TIM_barrel (Dus) Nucleus dus1 YML080W
Nucleus/cytoplasm dus2 YNR015W
Nucleus/cytoplasm dus3 YLR401C
– dus4 YLR405W
6 1.3.3.1 Dihydroorotate dehydrogenase FMN TIM_barrel (DHO_dh) Cytoplasm ura1 YKL216W
7 1.3.3.4 Protoporphyrinogen IX oxidase FAD NADP_Rossmann
(Amino_oxidase)
I. mito. membr. hem14 YER014W
8 1.3.3.6 Acyl-CoA oxidase FAD Acyl-CoA_dh (ACOX, acyl-
CoA_dh_1)
Peroxisome pox1 YGL205W
9 1.3.5.1 Succinate dehydrogenase 8α-(N3-His) NAPH_Rossmann I. mito. membr. sdh1 YKL148C
Flavoprotein subunit A -FAD/2Fe-2S/ (FAD_binding_2) sdh1b YJL045W
– Protein required for ﬂavinylation of sdh – – I. mito. membr. emi5 YOL071W
10 1.4.1.14 NAD-dependent glutamate synthase FMN/3Fe-4S Glu_synthase/
Glu_syn_central
Mito. matrix glt1 YDL171C
11 1.4.3.5 Pyridoxal 5′-phosphate oxidase FMN FMN-binding Mito. intermembr. sp. pdx3 YBR035C
Pyridoxine 5′-phosphate oxidase (Pyridox_oxidase)
12 1.4.3.17 Polyamine oxidase FAD NADP_Rossmann cytoplasm fms1 YMR020W
(FAD_binding_2)
13 1.5.1.20 Methylenetetrahydrofolate reductase FAD FAD_oxidored (MTHFR) – met12 YPL023C
Mito. met13 YGL125W
14 1.5.5.1 Electron-transferring ﬂavoprotein-
ubiquinone oxidoreductase
FAD/4Fe–4S 4Fe–4S (ETF_QO) I. mito. membr. cir2 YOR356W
15 – Electron transferring ﬂavoprotein FAD FAD_DHS (ETF_alpha) Mito. matrix aim45 YPR004C
16 1.5.99.8 Proline dehydrogenase FAD FAD_oxidored (Pro_dh) Mito. matrix put1 YLR142W
17 1.6.2.2 Cytochrome-b5 reductase FAD FAD_Lum_binding ER & o. mito. membr. cbr1 YIL043C
(FAD_binding_6) ER & plasma membr. pga3 YML125C
18 1.6.2.4 NADPH-hemoprotein reductase FMN/heme Flavoprotein
(Flavodoxin_1)
O. mito. membr., ncp1 YHR042W
(cytochrome P450 reductase) FAD FAD_Lum_binding ER & plasma membr.
(FAD_binding_1)
19 1.6.5.2 NAD(P)H quinone oxidoreductase FMN Flavoprotein
(Flavodoxin_2)
cytoplasm lot6 YLR011W
20 1.6.5.9 NADH-ubiquinone oxidoreductase (rotenone-
insensitive)
FAD/Fe-S NADP_Rossmann
(Pyr_redox_2)
I. mito. membr. ndi1 YML120C
21 1.6.99.1 NADPH dehydrogenase FMN TIM_barrel
(Oxidored_FMN)
Cytoplasm oye2 YHR179W
oye3 YPL171C
22 1.–.–.– External NADH dehydrogenase FAD – I. mito. membr. nde1 YMR145C
I. mito. membr. nde2 YDL085W
23 1.6.–.– NADPH-dep. diﬂavin oxidoreductase FMN Flavoprotein
(Flavodoxin_1)
Mito. matrix tah18 YPR048W
FAD FAD_Lum_binding
(FAD_binding_1)
24 – 5-Carboxymethylaminomethylation of uri-
dine (heterodimer with Mss1p)
FAD GIDA Mito. mto1 YGL236C
25 – Wybutosine biosynthesis, a tRNA-
modiﬁcation
FMN/4Fe–4S Flavoprotein ER tyw1 YPL207W
26 1.8.1.2 Sulphite reductase (beta subunit) FMN/heme Flavoprotein
(Flavodoxin_1)
Cytoplasm met5 YJR137C
FAD FAD_Lum_binding
(FAD_binding_1)
27 1.8.1.4 Dihydrolipoyl dehydrogenase FAD NADP_Rossmann Mito. matrix lpd1 YFL018C
(Pyr_redox_2)
28 1.8.1.7 Glutathione-disulﬁde reductase FAD NADP_Rossmann
(Pyr_redox_2)
Cytoplasm & mito. glr1 YPL091W
29 1.8.1.9 Thioredoxin-disulﬁde reductase FAD NADP_Rossmann
(Pyr_redox_2)
Cytoplasm & mito.
intermembr. sp.
trr1 YDR353W
Cytoplasm & mito. trr2 YHR106W
30 – Microtubule associated protein FAD NADP_Rossmann? cytoplasm irc15 YPL017C
(Pyr_redox_2) microtubule
31 1.8.3.2 Sulfhydryl oxidase FAD/Fe–S cluster/ Erv1_Alr Mito. intermembr. sp. erv1 YGR029W
Heme ER membr. erv2 YPR037C
32 1.8.4.- Endoplasmic oxidoreductin 1 FAD Ero1 ER & ER membr.e ero1 YML130C
33 1.14.12.17 Nitric oxide oxidoreductase FAD/heme FAD_Lum_Binding Cytoplasm yhb1 YGR234W
(ﬂavohemoglobin) (FAD_binding_6) Mito. matrix
34 1.14.13.– Oxidase of thiols in the ER FAD – ER membr. fmo1 YHR176W
35 1.14.13.9 Kynurenine 3-monooxygenase FAD O. mito. membr. bna4 YBL098W
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Table 1 (continued)
No. E.C. Enzyme Cofactor Structure clan (family)a Localization Abbrev. Syst. name
NADP_Rossmann
(FAD_Binding_3)
36 1.14.99.7 Squalene monooxygenase FAD – ER membr. erg1 YGR175C
37 1.14.99.- Monooxygenase in coenzyme Q biosyn. FAD – I. mito. membr. coq6 YGR255C
38 1.–.–.– Ferric reductase FAD/heme – Plasma membr. fre1 YLR214W
Plasma membr. fre2 YKL220C
Plasma membr. fre3 YOR381W
Plasma membr. fre4 YNR060W
Plasma membr. fre5 YOR384W
Vacuole membr. fre6 YLL051C
Plasma membr. fre7 YOL152W
– fre8 YLR047C
39 1.–.–.– NADPH oxidase FAD/heme – Perinucl. ER membr. aim14 YGL160W
40 1.–.–.– NAD(P)H-dep. heme reductase FAD – Inner mito. membr. cyc2 YOR037W
41 2.2.1.6 Acetolactate synthase FAD/TPP FAD_DHS
(TPP_enzyme_M)
Mito. ilv2 YMR108W
42 2.3.1.86 Fatty acid synthase, subunit β, chain I FMN Not reported Cytoplasm & mito. fas1 YKL182W
43 4.1.1.36 4′-Phosphopantothenoylcysteine
decarboxylase (forms a heterotrimeric
complex with Sis2p and Vhs3p)
FMN Flavoprotein Cytoplasm cab3 YKL088W
44 4.1.99.3 Deoxyribodipyrimidine photo-lyase FAD HUP (DNA_photolyase) Cytoplasm, mito. & nucleus phr1 YOR386W
45 4.2.3.5 Chorismate synthase FMN Chorismate_synt Cytoplasm aro2 YGL148W
46 – Flavodoxin-like protein FMN Flavoprotein
(Flavodoxin_1)
Cytoplasm, mito. pst2 YDR032C
– Flavodoxin-like protein FMN Flavoprotein
(Flavodoxin_1)
Cytoplasm rfs1 YBR052C
– ﬂavodoxin-like protein FMN Flavoprotein
(Flavodoxin_1)
Cytoplasm, mito. ycp4 YCR004C
47 – Apoptosis-inducing factor FAD – O. mito. membr., plasma
membr. & nucleus
aif1 YNR074C
Abbreviations used in Table 1: biosyn., biosynthesis; dh, dehydrogenase; degr., degradation; dep., dependent; i., inner; ER, endoplasmic reticulum; mito., mitochondrion; o., outer;
perinucl., perinuclear; red., reductase; sp., space.
a Pfam classiﬁcation given in plain text is for yeast proteins and those in italics are for homologs from other species.
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idatively damaged proteins of the cytoskeleton, such as actin [5].
2. General aspects of the yeast ﬂavoproteome
The yeast genome contains 68 genes encoding for a ﬂavin-
dependent protein and thus 1.1% of all yeast proteins (5885
protein-encoding genes [26]) have a requirement for either FMN or
FAD. Owing to the presence of several ﬂavoprotein families, which
will be discussed further below, these 68 genes give rise to 47 de-
ﬁned biochemical roles. Thirty-ﬁve ﬂavoproteins require FAD (74%)
and ﬁfteen require FMN (26%). Yeast also possesses three diﬂavin
enzymes, which harbor both FMN and FAD (Table 1). The utilization
of FMN and FAD in yeast ﬂavoproteins is very similar to the distribution
found in a global analysis across all kingdoms of life [27] and does not
have the bias towards FAD as found for the human ﬂavoproteome
[28]. Covalent ﬂavinylation, which is statistically found in ca. 10% of ﬂa-
voproteins, is underrepresented in the yeast ﬂavoproteome with only
two enzymes, succinate dehydrogenase (Sdh1p) and L-arabinono-1,4-
lactone oxidase (Alo1p) featuring a covalent bond between the N(3)-
nitrogen of a histidine residue and the 8-methyl group of the isoalloxa-
zine ring system (Table 1). Both of these enzymes operate in yeast
mitochondria and are located in the inner (Sdh1p) and outer (Alo1p)
membrane. The scarcity of covalent ﬂavoproteins is linked to the rela-
tive absence of the structural clan FAD_PCMH (with the exception of
Alo1p), which features many examples of mono- and even bi-covalent
ﬂavinylation [27,28].
Structural information through X-ray crystallographic analysis is
available for about one third of yeast ﬂavoproteins listed in Table 1
(plain font in column “Structure clan/family”). In addition, the
three-dimensional structure can be inferred from the known struc-
ture of homologs from other species (italics in column “Structure
clan/family”). In some cases the structure of yeast ﬂavoproteins
served as paradigms for a family of enzymes, for example yeast
OYEs [6,29] and more recently kynurenine monooxygenase [30].The general difﬁculties to elucidate the structure of integral or mem-
brane associated proteins is also seen for ﬂavoproteins (see Table 1).
Table 1 also provides information on the localisation of ﬂavoproteins
in the yeast cell. More than half of yeast ﬂavoproteins (36 entries in
Table 1) operate in themitochondrion.Many of these are directly partic-
ipating in redox reactions connected to the electron transport chain
(ETC) (see also next section). Seventeen ﬂavoproteins are located in
the cytoplasm and only a few in the nucleus (Dus1-4p, Phr1p, Aif1p),
endoplasmic reticulum (Aim14p, Cbr1p, Erg1p, Ero1p, Erv2p, Fmo1p,
Ncp1p, Pga3p, Tyw1p) or the peroxisome (Pox1p). Requirement for
the same ﬂavoenzyme activity in different cellular compartments is ei-
ther satisﬁed by expression of isozymes (e.g. Dld1-3p are found in either
the cytoplasm, the innermitochondrialmembrane or thematrix) or the
same ﬂavoenzyme is present in multiple compartments (e.g. Cbr1p,
Pga3p, Ncp1p, Trr1/2p, Yhb1p, Fas1p, Phr1p, Aif1p).
3. Flavoproteins, the stewards of iron
A remarkable result of our analysis concerns themulti-layered re-
lationship between ﬂavins and iron. As discussed in more detail in
the next section, ﬂavin-dependent ferric reductases (Fre1p-8p) are
essential for reduction of ferric iron (and copper), which is prerequi-
site for iron (and copper) uptake by yeast transporters (permeases).
Moreover, in several ﬂavoproteins the ﬂavin is responsible for the re-
duction of either heme iron or an iron–sulfur cluster (Table 1 and
Scheme 1). Prominent examples include succinate dehydrogenase
(Sdh1p), (Aim1p), nitric oxide oxidoreductase and L-lactate:cyto-
chrome c oxido reductase (ﬂavocytochrome b2). In addition to this
intramolecular electron transfer, two yeast ﬂavoproteins, Cyc2p
and Tah18p, are involved in intermolecular electron transfer. In the
case of Cyc2p, which is located in the inner mitochondrial membrane
with its FAD-containing active site exposed to the intermembrane
space, the enzyme reduces Fe(III) and participates in the incorpora-
tion of the heme prosthetic group into apocytochrome c and c1
[31,32]. Similarly, the diﬂavin reductase Tah18p forms a complex
Scheme1. Flavoproteins inmitochondrial redox processes. Flavoproteins are represented by yellow spheres (soluble ﬂavoproteins in thematrix or intermembrane space) or barrels (inner
or outermitochondrial membrane). Flavoproteins with a covalently bound FAD (Sdh1p in the inner and Alo1p in the outermembrane) are shown in light orange. Cytochrome c is shown
as a light green sphere. Curved blue arrows indicate redox reactions and straight arrows electron transfer. For further explanations and comments see main text. Several ﬂavoproteins
appear to participate in a multi-protein complex in the inner mitochondrial membrane [57]. For clarity, we have shown only a complex consisting of Ndi1p, Nde1/2p and Gut1p. Abbre-
viations used are: DHAP, dihydroxy acetone phosphate; Gly3p, glycerol 3-phosphate; GluSA, γ-glutamic acid semialdehyde; Mia(40), mitochondrial intermembrane space import and
assay/oxidoreductase 40 (ox, oxidized; red, reduced); Q, ubiquionone.
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biosynthesis of two iron–sulfur clusters [33]. Recently, Tah18p was re-
ported to be involved in NO generation in yeast and hence it is conceiv-
able that it has more clients than Dre2p [34]. Thus ﬂavoproteins fulﬁll
various crucial tasks ranging from iron uptake, delivery of electrons to
the mitochondrial electron transport chain, reduction of cytochrome-
dependent reductases, biogenesis of iron–sulfur clusters and insertion
of the heme cofactor into apocytochromes.
4. Flavoprotein families in yeast
As mentioned above, the yeast ﬂavoproteome contains several
families of ﬂavoproteins, which catalyze identical or similar reac-
tions. The largest group are the ferric/cupric reductases encoded by
fre1-8 (see Table 1, entry 38). Fre1 and fre2 are metalloregulated by
either iron or copper availability and the encoded metalloreductases
reduce Fe(III) and Cu(II) at the expense of NADPH [35]. In addition to
fre1 and fre2, the yeast genome contains six homologous genes,
termed fre3-8. Fre3-6 are regulated by iron whereas fre7 is copper-
regulated [36,37]. Fre8 and the homologous aim14 are not regulated
by iron or copper suggesting a different role for these proteins [36].
Recently, it was demonstrated that aim14 encodes an NADPH-
oxidase, which produces superoxide in the endoplasmatic reticulum
[38] and it is thus conceivable that fre8 also encodes an enzyme with
similar properties. This notion is also supported by pair-wise se-
quence alignments showing the highest identity (30.6%) and simi-
larity (56.5%) on the amino acid level between fre8 and aim14
within this family of ﬂavoproteins [36]. Again, these functions high-
light the importance of ﬂavoenzymes for iron uptake and reduction
as introduced in the previous section.The second largest family comprise four tRNA-dihydrouridine
synthases encoded by dus1-4 (Table 1, entry 5). The reduction of ura-
cils to dihydrouridines in tRNA is one of the most common modiﬁca-
tions of nucleosides in tRNA in all kingdoms of life [39]. A recent
mechanistic study employing Dus2p revealed that reduction of uracil
to dihydrouracil (see Scheme 2, top) is promoted by other tRNA
modiﬁcations suggesting that tRNAmaturationmay occur in anordered
fashion [40]. Cytoplasmic tRNA in S. cerevisiae contains dihydrouridine
in the D loop at positions 16, 17, 20, 20A, 20B and at the base of the var-
iable arm at position 47. The four yeast enzymes exclusively reduce ura-
cils in speciﬁc positions in tRNA: Dus1p reduces uracils in positions 16
and 17, Dus2p in position 20, Dus3p in position 47 and Dus4p in posi-
tions 20a and 20b. Thus these four enzymes are sufﬁcient to generate
all dihydrouridine modiﬁcations known in yeast [41]. In humans, only
one dihydrouridine synthase homologous to yeast Dus2p (42% identity)
was identiﬁed so far, which reduces uracil in tRNA for phenylalanine
[28,42]. The human enzyme appears to be upregulated inmalignant tis-
sues resulting in higher levels of dihydrouridine [42]. Despite its puta-
tive role in malignancy the speciﬁcity and exact role of the human
enzyme remains unclear.
In addition to reductionof uracil, theﬂavoenzymeMto1p (also termed
GidA) is involved in thebiosynthesis ofmodiﬁcations at the C5-position of
the uracil base in tRNAs [43,44]. Depending on the nitrogen source,
ammonia or glycine, this reaction leads to the formation of either 5-
aminomethyl- or 5-carboxymethylaminomethyluridine (Scheme 2,
bottom). Thismodiﬁcation occurs at thewobble position inmitochondrial
tRNAs for lysine, glutamate and glutamine [44]. Detailed characterization
of the bacterial protein complex of MnmE and MnmG (homolog of
Mto1p) led to a mechanistic proposal in which the FAD-dependent
MnmG serves a dual function during the reaction [43,45]. In this model,
Scheme 2. Flavoproteins in tRNA-modiﬁcation. Top, reaction catalyzed by tRNA-dihydrouridine synthase (Dus1-4p); Bottom, reaction catalyzed by Mto1p/Mss1p. Depending on the co-
substrate, ammonia or glycine, the side chain in position 5′ of the uracil base is aminomethyl or carboxymethylaminomethyl. “R” represents the next 3′-nucleotide in the tRNAmolecule.
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or glycine to formamethylene aminogroup atN-5 of the tetrahydrofolate
cofactor. Then, FAD oxidizes the carbon–nitrogen bond to yield an imine,
which is then nucleophilically attacked by the uracil base of the tRNA sub-
strate. In the next step the reduced FAD transfers a hydride to the imine to
reduce the carbon–nitrogen double bond thus completing the biosynthe-
sis of the C-5 side chain (see Scheme 2). Thus MnmG combines two ca-
nonical ﬂavin-dependent reactions – oxidation of amines and reduction
of double bonds – to catalyze the biosynthesis of the amino methyl or
carboxymethylaminomethyl side chain.
Recently, yet another ﬂavin-dependent enzyme encoded by tyw1
(Table 1, entry 25) was discovered that catalyzes the second step in
the biosynthesis of wybutosine-modiﬁed tRNA [46]. This enzyme be-
longs to the radical SAM superfamily characterized by the presence of
a [4Fe–4S] cluster and a S-adenosylmethionine (SAM) domain [47]. Cat-
alytic activity requires reduction of the [4Fe–4S] cluster in order to ini-
tiate one-electron transfer for reductive cleavage of SAM to generate
the 5′-deoxyadenosyl radical [48]. In vivo, ﬂavodoxins or ferredoxins
might act as potential electron donors to convert [4Fe–4S]2+ to [4Fe–
4S]+ and therefore it is conceivable that the N-terminal ﬂavodoxin do-
main of Tyw1p relays electrons from an external electron donor such
as NAD(P)H or an electron transfer protein to the [4Fe–4S] cluster.
Such a functional role is supported by the ﬁnding that deletion of the
ﬂavodoxin domain abolishes TYW1p activity [49].
Interestingly, the yeast genome contains three homologous genes,
pst1, rfs1 and ycp4 encoding three highly similar ﬂavodoxin-like pro-
teins (Table 1, entry 46) [50]. Although none of the proteins was func-
tionally characterized with respect to their electron transfer properties
and physiological redox partners they were found to act as transcrip-
tional regulators of spi1, a gene responding to various environmental
stimuli [51]. The lack of information on yeastﬂavodoxins is very surpris-
ing in view of the abundance of structural (148 structures of wild-type
and variants in the pdb) and biochemical studies available for bacterial
ﬂavodoxins. Therefore, the current state of affairs for yeast ﬂavodoxin-
like proteins is very unsatisfactory and clearly warrants further investi-
gations to deﬁne their biochemical and structural properties.
The family of D-lactate dehydrogenases comprising three enzymes,
Dld1-3p, will be discussed in the context of redox processes in the
next section.5. Yeast ﬂavoproteins in redox balancing
More than a quarter of yeast ﬂavoproteins listed in Table 1 partic-
ipate in redox reactions in themitochondrion. As shown in Scheme 1,
transfer of electrons into the ETC can either occur through electron
donation to cytochrome c (cyt. c) in the intermembrane space or di-
rectly by reduction of ubiquinone to ubiquinol in the inner mito-
chondrial membrane. The latter route is clearly the dominating
process in yeast mitochondria. Electrons transferred to NAD+ in
the isocitrate, α-ketoglutarate and malate dehydrogenase reactions
of the tricarboxylic acid cycle enter the ETC. via the NADH:ubiqui-
none oxidoreductase Ndi1p (“internal NADH dehydrogenase”). In
contrast to complex I of higher eukaryotes this membrane-bound
enzyme does not engage in proton translocation resulting in lower
phosphorylation efﬁciency. Theoxidation of succinate to fumarate is cat-
alyzed by a canonical membrane-bound succinate dehydrogenase in
which the covalently linked FAD becomes reduced by the substrate
and the electrons are passed on to ubiquinone via an iron–sulfur cluster
and heme relay system. The Sdh1p subunit of yeast succinate dehydro-
genase (complex II) is one of only two ﬂavin-dependent proteins
exhibiting a covalent linkage (see Table 1, entry 9). Typically, covalent
ﬂavinylation is a spontaneous co- or posttranslational process. However,
in the case of Sdh1p the assistance of Emi1p (Sdh5p) is required, which
is conserved in higher eukaryotes and hence appears to be essential for
complex II assembly [52,53]. Yeast also possesses a heterodimeric elec-
tron transfer ﬂavoprotein (Aim45p/Cir1p) located in the mitochondrial
matrix, which communicates with a membrane-bound electron trans-
ferringﬂavoprotein ubiquinoneoxidoreductase (Cir2p). The latterﬂavo-
protein feeds electrons received from Aim45p/Cir1p into the ETC. The
clients for Aim45p/Cir1p, however, remain elusive as most electron
donor proteins, such as the acyl-Co dehydrogenases involved in β-
oxidation or amino acid degradation, are not present in S. cerevisiae. A
potential candidate, L-proline dehydrogenase (Put1p), evidently feeds
electrons from L-proline oxidation directly into the ETC. by reduction
of ubiquinone to ubiquinol (see Scheme 1) [54].
Cytosolic NADH generated for example by the glycolytic enzyme
glyceraldehyde 3-phosphate dehydrogenase is oxidized by either
Nde1p or Nde2p (“external NADH:ubiquinone oxidoreductases”)
and the electrons serve to reduce ubiquinone (Scheme 1). The
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shuttle: glycerol is ﬁrst phosphorylated by glycerol kinase (Gut1p)
in the cytosol and then transported to the intermembrane space to
become oxidized by the membrane-bound glycerol 3-phosphate de-
hydrogenase (Gut2p) [55,56]. Several of the membrane-bound ﬂa-
voproteins involved in substrate oxidation and electron transfer
form a large supramolecular complex containing Nde1p, Nde2p and
Gut2p and therefore inter-protein electron transfer may also occur
prior to ubiquinone reduction [57].
Yeast possesses three D-lactate dehydrogenases (Dldp1-3, see
Table 1), which operate in different compartments of the cell:
Dld1p is located in the inner mitochondrial membrane, Dld2p in
the matrix and Ddl3 in the cytosol [58,59]. D-lactate is produced by
the glyoxalase pathway that detoxiﬁes methylglyoxal adventitiously
generated by non-enzymatic elimination of hydrogen and phosphate
from the enediol intermediate of triose phosphates [60]. Since this
detoxiﬁcation pathway is active in the cytosol and the mitochondrial
matrix D-lactate dehydrogenase activity is required in these com-
partments to oxidize D-lactate to pyruvate (Scheme 1). Oxidation
of D-lactate by the D-lactate dehydrogenase (Dld2p) localized in the
mitochondrial matrix is coupled to ATP synthesis and therefore
Dld2p apparently donates substrate-derived electrons to the ETC
[61]. However, it is currently unknown whether electrons are directly
used to reduce ubiquinone or transferred to the heterodimeric
Aim45p/Cir2p electron transfer complex (Scheme 1).
The involvement of ﬂavoproteins in central mitochondrial redox
processes is also reﬂected by the fact that the ﬂavin oxidation state
oscillates in synchronized aerobically grown yeast cultures. During the
oxidative phase of the culture the increase of ﬂavin ﬂuorescence indi-
cates thatmore ﬂavoproteins becomeoxidizedwhereas in the reductive
phase of the internal rhythm a decrease of ﬂavin ﬂuorescence indicates
a shift to the reduced state [62,63].
6. Flavin biosynthesis and transport
The biosynthesis of riboﬂavin in S. cerevisiae utilizes the canonical
precursors, GTP and ribulose 5-phosphate. However, riboﬂavin biosyn-
thesis deviates from the bacterial pathway in that deamination and re-
duction of the initial metabolite, 2,5-diamino-6-(ribosylamino)-4-
(3H)-pyrimidinone 5′-phosphate (DRAP), take place in reverse order
(www.kegg.jp). Brieﬂy, in the ﬁrst step GTP is converted by GTP
cyclohydrolase II, encoded by rib1, to DRAP, which is reduced by Rib7p
to 2,5-diamino-6-(ribitylamino)-4-(3H)-pyrimidinone 5′-phosphate
(Table 2 and Scheme 3). This reaction is followed by deamination to
5-amino-6-ribitylamino-2,4-(1H,3H)-pyrimidinedione 5′-phosphate
catalyzed by Rib2p [64]. After dephosphorylation by an unidentiﬁedTable 2
Yeast ﬂavin transporters and biosynthesis.
No. E.C. Protein/enzyme Substrate
Transporters
1 – FAD transmembrane transporter FAD
2 – FAD transporter (into ER) FAD
3 – FAD transporter (into ER) FAD
4 – FAD transporter (into ER) FAD
5 – Plasma-membrane riboﬂavin transporter Riboﬂavin
Biosynthesis of riboﬂavin, FMN and FAD
1 3.5.4.25 GTP cyclohydrolase II (1st step) –
2 1.1.1.302 DRAP reductase (2nd step) –
3 – Deaminase (3rd step) –
4 4.1.99.12 DHBP synthase (4th step) –
5 2.5.1.78 Lumazine synthase (5th step) –
6 2.5.1.9 Riboﬂavin synthase (6th step) –
7 2.7.1.26 Riboﬂavin kinase Riboﬂavin
8 2.7.7.2 FAD-adenylyl transferase (synthetase) FMN
Abbreviations used in Table 2 are: DHBP, 3,4-dihydroxy-2-butanone-4-phosphate; DRAP, 2,5-d
a Pfam classiﬁcation given in plain text is for yeast proteins and those in italics are for homophosphatase condensation with 3,4-dihydroxy-2-butanone-4-phos-
phate (DHAB) occurs. The latter metabolite is synthesized from ribulose
5-phosphate byDHBP synthase (encoded by rib3). The condensation re-
action is catalyzed by lumazine synthase (encoded by rib4) and yields
6,7-dimethyl-8-(1-D-ribityl)lumazine [65,66]. In the ﬁnal reaction, ribo-
ﬂavin synthase (encoded by rib5) uses two molecules of 6,7-dimethyl-
8-(1-D-ribityl)-lumazine where one acts as donor and the other as
acceptor of four carbon atoms leading to the generation of the isoallox-
azine ring of one molecule of riboﬂavin [67]. The coenzyme forms of
riboﬂavin, FMN and FAD, are synthesized from riboﬂavin by riboﬂavin
kinase (Fmn1p) and FAD synthetase (Fad1p), respectively [68,69].
In addition to de novo biosynthesis, yeast is also capable of riboﬂavin
uptake from the medium and it was shown that a plasma membrane
ﬂavin transporter, encoded by mch5, is regulated by the proline-
dependent transcription factor Put3p [70,71]. Since proline utiliza-
tion depends on the FAD-dependent proline dehydrogenase Put1p
(Table 1) upregulation of Mch5p suggests that riboﬂavin uptake is
necessary under these conditions to meet the cellular demand for
ﬂavin coenzymes.
Despite the wealth of genetic and biochemical information available
on riboﬂavin biosynthesis in the cytosol, transport to other compart-
ments, in particular themitochondrion as the dominant organelle for
ﬂavoenzyme catalyzed reactions, remains controversial [53]. Based
on the ﬁnding that yeast mitochondria possess riboﬂavin kinase
but no FAD synthetase activity, Tzagaloff et al. [72] proposed a
model according to which the carrier protein Flx1p acts as a “ﬂavin
antiporter” by exchanging FMN from the mitochondrial matrix
with FAD from the cytosol. In contrast to this model, Barile and co-
workers claim that riboﬂavin is transported into mitochondria
where both FMN and FAD can be synthesized and are even exported
back to the “extramitochondrial phase” [73,74]. More recent data
from Pallotta indicated that mitochondria can also hydrolyze FAD
and FMN to riboﬂavin and are thus capable of balancing the pools
of riboﬂavin, FMNand FAD [75]. Yeast FAD synthetase (Fad1p) is essential
and deletion of fad1makes yeast unviable. The localization of yeast FAD1p
is still unclear, although recent studies on human FAD synthetase isoform
1 (hFADS1) suggest a mitochondrial localization in eukaryotes [76].
In addition to ﬂx1 andmch5, yeast possesses three ﬂc genes encoding
putative transporters of ﬂavins (Table 2). These transporters are re-
sponsible for FAD transport into the endoplasmic reticulum (ER)
where several ﬂavoenzymes (e. g. Ero1p, Erv2p and Fmo1p) are in-
volved in the redox balance of thiols and disulﬁde linkages [77].
However, the exact role and localisation of Flc1-3p in yeast are cur-
rently not fully understood.
An alternative mechanism for assembling the holo-ﬂavoenzyme
is realized for the sole peroxisomal ﬂavoenzyme, acyl-CoA oxidase/ligand Structure clan (family)a Abbrev. Syst. name
– ﬂx1 YIL134W
– ﬂc1 YPL221W
– ﬂc2 YAL053W
– ﬂc3 YGL139W
– mch5 YOR306C
GTP cyclohydrolase II rib1 YBL033C
DHFred (RibD_C) rib7 YBR153W
DHFred (RibD_C) rib2 YOL066C
DHBP_synthase rib3 YDR487C
DMRL_synthase rib4 YOL143C
FAD_Lum_binding (Lum_binding) rib5 YBR256C
Flavokinase fmn1 YDR236C
HUP (PAPS_reduct) fad1 YDL045C
iamino-6-ribosylamino-4(3H)-pyrimidinone 5′-phosphate.
logs from other species.
Scheme 3. Biosynthesis of riboﬂavin in S. cerevisiae. GTP and D-ribulose-5-phosphate serve as building blocks for the biosynthesis of 5-amino-6-ribityl-aminouracil and 3,4-dihydroxy-2-
butanone-4-phosphate, respectively. These two compounds are then used by Rib4p to synthesize 6,7-dimethyl-8-ribityl lumazine. Two molecules 6,7-dimethyl-8-ribityl lumazine
areconverted by Rib5p to riboﬂavin and 5-amino-6-ribityl-aminouracil which serves again as substrate for Rib4p. This way all atoms of the dimethylbenzene moiety are derived from
3,4-dihydroxy-2-butanone-4-phosphate (colored in blue and green) while remainder of riboﬂavin is derived from GTP (colored in red).
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binds to the import receptor Pex5p and, following an unknown im-
port pathway, is transported into the peroxisome [78,79].
7. Yeast ﬂavoproteins as models for human diseases
The yeast S. cerevisiae has been used as a model organism for
studying fundamental biological processes for some time [80]. In
1997, Botstein and colleagues showed that nearly 31% of yeast open
reading frames (ORF) have a homologue in mammalian genomes [81].
Since the number of annotated ORFs has almost doubled since 1997
this percentage is likely to have risen signiﬁcantly. Moreover, an esti-
mated 30% of human genes implicated in human diseases have a yeast
homologue [82]. In a recent review, we have documented that ﬁfty
human ﬂavoproteins are implicated in human diseases [28]. As shown
in Table 3, nearly half of the disease-related human ﬂavoproteins pos-
sess a yeast homologue. Interestingly, the majority of disease-related
human ﬂavoproteins operate in the mitochondrion [28]. Owing to the
similarity of mitochondrial processes in eukaryotes it is conceivable
that the yeast homologs located in mitochondria (see Table 3) may be
particularly suitable as models for an improved understanding of
human mitochondrial diseases.
Functional assignments based on sequence similarity generated
ambiguities for several ﬂavoproteins. For example, the yeast D-lactate
dehydrogenases (Dld1-3p) show remarkable similarity to human D-2-
hydroxyglutarate dehydrogenase and to a much lesser degree to
alkyldihydroxyacetone phosphate synthase. Similarly, the yeast gluta-
mate synthase, Glt1p, exhibits similarity to human dihydropyrimidine
dehydrogenase (see Table 3). On the other hand the yeast NAD(P)H:
quinone oxidoreductase Lot6p shows only a very low similarity to the
human ortholog (P = 1) although it possesses a similar structure andfunction [83–86]. These examples illustrate the need for biochemical
characterization to provide a solid basis for comparative functional
studies.
Yeast deletion strains were also used as convenient models to in-
vestigate the impact of mutations discovered in human genes. Exam-
ples are deletions of the genes ura1, sdh1, ldp1 and coq6, leading to
auxotrophic yeast strains, which were complemented with the
orthologous human gene to investigate the functional impairment
of mutations [87–90]. Yeast was also utilized as a host for heterolo-
gous expression of the human gene encoding 3β-hydroxysterol
Δ24-reductase (DHCR24). Desmosterolosis, a rare autosomal reces-
sive disorder is caused by mutations in the gene encoding DHCR24.
Heterologous expression of the human DHCR24 gene bearing differ-
ent missensemutations conﬁrmed their role in desmosterolosis [91].
A genetic screen in yeast suggested that kynurenine 3-
monooxygenase may be a useful therapeutic target for Huntington
disease [92]. This has prompted structural studies with the yeast en-
zyme leading to the elucidation of its X-ray crystal structure, which
may serve as amodel to investigate the structural basis of inhibitor bind-
ing [30]. Similarly, the crystal structure of the yeast ﬂavin-containing
monooxygenase Fmo1p proved useful as a model to understand the
effect of mutations in human FMO3 that cause trimethylaminuria
(“ﬁsh-odor” syndrome) [93].
8. Concluding remarks
Our analysis of the yeast ﬂavoproteome has highlighted the impor-
tance of ﬂavin-dependent enzymes in mitochondrial redox processes.
Many of these mitochondrial enzymes have human homologs involved
in diseases and thus geneticallymanipulated yeast strains (e.g. gene de-
letions) have potential as convenientmodel systems. On the other hand,
Table 3
Yeast ﬂavoproteins as human disease models.
No. E.C. Human enzyme Disease OMIM Yeast homolog E valuea
1 1.1.5.3 Glycerol 3-phosphate dh Diabetes mellitus, type 2 138430 Gut2p 7.3 e−124
2 1.1.99- D-2-Hydroxyglutarate dh D-2-Hydroxyglutaric aciduria 605176 Dld1p 1.9 e−39
Dld2p 8.7 e−128
Dld3p 3.3 e−112
3 1.3.1.2 Dihydropyrimidine dh Deﬁciency 612779 Glt1p 2.7 e−14
4 1.3.5.2 Dihydroorotate dh Miller syn. 126064 Ura1p 2.0 e−6
5 1.3.3.4 Protoporphyrinongen IX ox. Variegate porphyria 600923 Hem1p 7.2 e−20
6 1.3.3.6 Acyl-CoA ox. Deﬁciency 609751 Pox1p 2.0 e−45
7 1.3.5.1 Succinate dh Complex II deﬁciency, 600857 Sdh1p 3.9 e−219
Flavoprotein subunit A Leigh syn., paraganglioma 5 Sdh1bp 3.0 e−214
8 1.4.3.4 Monoamine ox Brunner syn., antisocial behavior, autism 309850 Fms1p 7.8 e−11
9 1.4.3.5 Pyridoxine 5′-phosphate ox. Encephalopathy 603287 Pdx3p 5.1 e−36
10 1.5.1.20 Methylenetetrahydofolate red. Homocystinuria, neural tube 607093 Met12p 2.9 e−98
Defects, schizophrenia Met13p 7.5 e−122
11 1.5.5.1 Electron-transferring ﬂavo-protein ubiquinone oxidored. Glutaric academia IIC 231675 Cir2p 8.0 e−157
12 – Electron-transferring ﬂavoprot. Glutaric acidemia IIA 608053 Aim45p 8.5 e−66
Glutaric acidemia IIB 130410
13 1.5.99.8 Proline dh Hyperprolinemia type I, schizophrenia 606810 Put1p 8.7 e−12
14 1.6.2.2 Cytochrome-b5 red. Methemoglobinemia types I & II 613213 Cbr1p 1.9 e−30
15 1.6.2.4 NADPH-hemoprotein red. (cytochrome P450 red.) Antley–Bixler syn., 124015 Ncp1p 2.4 e−86
16 1.6.5.2 NAD(P)H:quinone oxidored. Benzene toxicity, breast cancer 125860 Lot6p 1
17 1.8.1.4 Dihydrolipoyl dh Leigh syn., maple syrup urine disease 238331 Lpd1p 2.8 e−147
18 1.8.1.7 Glutathione-disulﬁde red. Hemolytic anemia 138300 Glr1p 1.4 e−104
19 1.14.13.8 Flavin-containing monooxy. Trimethylaminuria 136132 Fmo1p 4.8 e−27
20 1.14.13.39 Nitric-oxide synthase Hypertension 163729 Tah18p 9.6 e−27
163730
21 1.14.99.- Monooxy. in coenzyme Q Deﬁciency, nephrotic syn. 614647 Coq6p 7.0 e−55
22 1.16.1.8 Methionine synthase red. Homocystinuria, neural tube 602568 Met5p 0.24
23 2.5.1.26 Alkyldihydroxyacetone Rhizomelic chondrodysplasia 603051 Dld1p 2.1 e−25
Phosphate synthase Punctata type 3 Dld2p 4.4 e−16
Dld3p 1.1 e−15
24 – Apoptosis inducing protein Combined oxidative phosphorylation deﬁciency 300169 Aif1p 8.8 e−4
Abbreviations used in Table 3: dh, dehydrogenase; ﬂavoprot., ﬂavoprotein; monooxy., monooxygenase; ox, oxidase; oxidored., oxidoreductase; red., reductase; syn., syndrome.
a E value; expect value, was generated by searching of Saccharomyces Genome Database (SGD; http://www.yeastgenome.org) open reading frames (DNA or protein) against human
protein sequences using the SGDWU_Blast2 program.
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biochemical properties, such as substrate speciﬁcity, kinetic parameters
and reaction partners. This deﬁcit is clearly illustrated by the yeast
ﬂavodoxin-like proteins and the electron-transferring ﬂavoprotein,
none of which were characterized in any biochemical or structural de-
tail. Similarly, our understanding of riboﬂavin uptake and trafﬁcking be-
tween cellular compartments as well as ﬂavin homeostasis are at an
early stage necessitating further studies. Since these processes are also
poorly understood in humans, yeast lends itself as a valuable model or-
ganism to gain insight into uptake, transport and trafﬁcking of this vital
vitamin.
9. Methods
The names and gene abbreviations of yeast ﬂavoproteins were re-
cently compiled for a review article [27]. This list of ﬂavoproteins
was updated using the information available in the Saccharomyces
genome database (http://www.yeastgenome.org/). This database
was also used to extract information on viability of gene knock-outs
and localisation of ﬂavoproteins in the yeast cell. Structural information
was obtained from the protein database (http://www.pdb.org).
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